The SEC published a Federal Register notice on October 1, 2026, describing TXSE’s proposed three-tier ETP listing-fee schedule of $10,000, $55,000, and $100,000 annually. The proposal also sets tiered liquidity-performance standards and daily stipends for lead market makers; it is a proposed rule change, not evidence of final approval or market impact.
Stories, market investigations, social-media posts, videos and graphics are for educational and informational purposes only. They are not investment, financial or trading advice, or a recommendation to buy, sell or hold any asset. Terms of Service
The reported regulatory event is verified, but the narrow market-quality thesis is not yet testable with observed outcomes. The SEC and Federal Register records confirm a TXSE proposal—not a demonstrated improvement in spreads or quoting persistence. The proposed design is directionally consistent with better liquidity: higher tiers impose tighter maximum spreads and stronger depth and NBBO-time requirements, while the exchange would pay stipends to lead market makers meeting the standards. That is a mechanism and an intention, not an observed effect.
The Federal Register notice states that TXSE filed the proposal on September 14, 2026 and describes three annual fee tiers: $100,000 Signature, $55,000 Premier, and $10,000 Core. It also lists market-quality measures including maximum LMM spread, size near the inside, layered depth, time at NBBO, auction depth, and auction reference-price standards. For U.S.-equity ETPs, the notice gives tier-specific maximum spreads of 20 basis points for Signature, 25 basis points for Premier, and 50 basis points for Core, plus NBBO quoting requirements for certain products. These standards support the inference that the program is designed to require more quoting quality at higher prices.
The strongest evidence against claiming the thesis has already been established is temporal and empirical: the notice is a proposed rule change, the SEC page identifies a public-comment deadline of October 22, 2026, and the retrieved materials contain no realized TXSE ETP spread panel, quote-presence history, implementation date, listing cohort, or matched comparison against Nasdaq, Cboe BZX, NYSE Arca, or another venue. The TXSE rules page lists the filing as a proposal and separately identifies related filings, but it does not provide post-implementation market-quality results.
A dated SPY daily-bar sample from September 1 through October 1, 2026 contains 22 observations and shows a September 30 close of $764.55; this is broad-market context only. Daily OHLCV bars cannot measure quoted bid-ask spreads, NBBO time, depth, or lead-market-maker persistence, and SPY is not a TXSE-listed treatment product. The available market recap was explicitly partial and did not supply ETP quote, venue, or flow data. Therefore it cannot establish market causation or an effect on ETF liquidity.
The proposal’s financial materiality to issuers and market makers is plausible but unquantified. The notice presents the exchange’s rationale that smaller or specialized ETPs can be costly to support and may experience wider spreads or liquidation, but those are TXSE’s assertions rather than independently measured outcomes. No TXSE issuer revenue, expected listing count, stipend budget, affected assets, or market-share estimate was retrieved. Direction is therefore unclear at the market level: the standards could improve displayed liquidity for participating products, while higher fees could raise launch costs or discourage marginal listings.
The Federal Register identifies SEC Release No. 34-106505, File No. SR-TXSE-2026-030, and states that TXSE filed the proposed rule change on September 14, 2026. The notice was published October 1, 2026.
Federal RegisterThe Federal Register notice describes Signature at $100,000 annually, Premier at $55,000 annually, and Core at $10,000 annually.
Federal RegisterThe notice lists maximum LMM spread, size near the inside, layered depth, time at NBBO, auction depth, and auction reference-price measures. For U.S.-equity ETPs, the displayed maximum spreads are 20 bps Signature, 25 bps Premier, and 50 bps Core.
Federal RegisterTXSE’s rules-and-filings page lists SR-TXSE-2026-027 with that description and a September 3, 2026 date.
Texas Stock Exchange Rules & FilingsThe SEC docket labels the matter a Notice and provides a public-comments-due date of October 22, 2026; the retrieved page supplies the notice and exhibits but no post-implementation quote-quality results.
U.S. Securities and Exchange CommissionThe Federal Register presents TXSE’s assertions about liquidity scarcity, wider spreads, poor executions, and fund liquidations as part of the exchange’s purpose and statutory-basis statement. The notice does not provide a treatment-control study or realized TXSE quote data.
Federal RegisterA 22-session SPY daily OHLCV sample from 2026-09-01 through 2026-10-01 provides prices and volume but no bid-ask quotes, NBBO duration, displayed depth, venue attribution, or TXSE treatment status.
Polygon historical bars via SentimentorWithout the actual implementation date and list of ETPs selecting each tier, a treatment sample cannot be defined.
The test requires time-stamped bid/ask, NBBO, displayed depth, and venue attribution for TXSE products and matched products elsewhere; daily bars are insufficient.
The proposal specifies standards, but no realized daily compliance, quote-presence, or stipend-payment records were retrieved.
A valid comparison needs matched ETPs by asset class, age, AUM, CADV, volatility, and strategy, plus pre/post periods and consistent spread units.
No evidence was retrieved quantifying affected assets, issuer listing-cost changes relative to issuer economics, expected TXSE listings, or exchange revenue impact.
The story concerns a proposed market-structure rule rather than a named security price move; no event-window abnormal-return, ETF-flow, options, or breadth dataset tied to the filing was retrieved.
Question tested: After implementation, do ETPs listed under TXSE’s fee tiers exhibit narrower spreads and more persistent market-maker quoting than comparable products listed elsewhere?
The filing and its fee and quoting provisions are verified, but the post-implementation proposition cannot yet be evaluated because no TXSE treatment cohort, implementation outcome, quote-level spread/depth data, or lead-market-maker persistence records were retrieved. The assessment would change with at least several weeks or months of post-launch quote data matched to comparable non-TXSE ETPs, together with verified tier selection and compliance records.
Open the full Augur reportStories reflect the evidence available at their stated cutoff, not a live market view. Prices, facts and conclusions may change. Check the dates, underlying sources and full assessment before relying on a summary.